Eliminating Patient Compliance and Achieve Better Patient Outcomes
FREMONT, CA: Surgery centers must take on a variety of factors, ranging from clinical and financial benefit to the impact on practice flow and logistics when deciding on whether to introduce new surgical techniques. In one such example, the pros and cons of various mydriasis approaches were evaluated during cataract surgery by administrators and surgeons. Keeping the tone and the size of the pupil and therefore a proper view of the operative field is important during the entire procedure to reduce the risk of capsules, vitreous loss, iris damage, and other possible operating problems. Challenges exist, as the surgeon seeks to achieve this goal, including a rising number of patients who have a history of systemic medications (known and unknown) that contribute IFIS and unpredictable dilation.
During surgery, preoperatively administered topical agents may be washed out and reduced. Although many surgeons have figured it effective to add or to deliver drug such as compounded epinephrine or phenylephrine during the course of surgery, the new standards for ambulatory surgery centers (ASC) in 2009 increased their scrutiny of these off-label practices. For continuous intracameral administration during cataract surgery, a combination of phenylephrine/ketorolac had been approved several years ago to lower the after operative pain and prevent pupil miosis.
Over one-third of patients with cataract surgery experience moderate to severe pain during their immediate post-operative period, and research has demonstrated that post-operative pain is undoubtedly a leading cause for unrest. In clinical trials, patients with a combination of fixed doses were more than 50 percent more likely to be pain-free. As a consequence, on the day of surgery with phenylephrine/ketorolac significantly fewer patients needed pain medicines, including opioids. New technologies can make practices more consistent between cases. The stability of iris can be removed entirely and the operating flow better anticipated, which increases efficiency by using phenylephrine/ketorolac.
By Leni Kaufman, VP & CIO, Newport News Shipbuilding
By George Evans, CIO, Singing River Health System
By John Kamin, EVP and CIO, Old National Bancorp
By Elliot Garbus, VP-IoT Solutions Group & GM-Automotive...
By Gregory Morrison, SVP & CIO, Cox Enterprises
By Alberto Ruocco, CIO, American Electric Power
By Sam Lamonica, CIO & VP Information Systems, Rosendin...
By Sergey Cherkasov, CIO, PhosAgro
By Pascal Becotte, MD-Global Supply Chain Practice for the...
By Stephen Caulfield, Executive Director, Global Field...
By Shamim Mohammad, SVP & CIO, CarMax
By Ronald Seymore, Managing Director, Enterprise Performance...
By Brad Bodell, SVP and CIO, CNO Financial Group, Inc.
By Jim Whitehurst, CEO, Red Hat
By Clark Golestani, EVP and CIO, Merck
By Scott Craig, Vice President of Product Marketing, Lexmark...
By Dave Kipe, SVP, Global Operations, Scholastic Inc.
By Meerah Rajavel, CIO, Forcepoint
By Amit Bahree, Executive, Global Technology and Innovation,...
By Greg Tacchetti, CIO, State Auto Insurance